HHS Releases White Paper Focused on Preventing Drug Shortages
The U.S. Department of Health and Human Services (HHS) has released a white paper highlighting steps the organization has taken to prevent and mitigate drug shortages and proposing additional solutions for policymakers to consider.
Pharmaceutical Market Withdrawals and Recalls: Expect the Unexpected
From minor violations to major safety concerns, sometimes medicines must be removed from the marketplace. Here’s the lowdown on how it’s handled.
How FDA’s Risk Management Program Can Help Prevent or Lessen Future Drug Shortages
Preparation and communication are key for mitigating the problems of a pinched drug supply and maintaining access to essential medications.
The Challenges of Drug Accessibility
Overall, medicines are widely available in the United States, but access issues persist due to a variety of factors, including shortages, reimbursement problems and waste.
